To determine immunological changes within the tumor that may contribute to the antitumoral response induced by the melphalan-based vaccine, the number of CD8+ T cells and tumor-specific CD8+ T cells were analyzed in the tumors. The gene discussed is CD8A; the disease is neoplasm.